USPTO serial 85368484
POWERING BETTER PRODUCTS WITH NEXT GENERATION SYNTHETIC BIOLOGY
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MARTIN, JENNIFER MCGARRY
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with POWERING BETTER PRODUCTS WITH NEXT GENERATION SYNTHETIC BIOLOGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DOYLE SIEVER
DOYLE SIEVER PRECIGEN, INC.20374 SENECA MEADOWS PARKWAYGERMANTOWN, MD 20876UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals, biochemicals and reagents for use in industry and science; Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for industrial and agricultural applications | ACTIVE | — |
| 005 | Chemical preparations for medical and veterinary purposes, namely, proteins for use in treating disease states, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents; Chemical preparations for medical and veterinary purposes, namely, chemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for medical and veterinary applications; Chemicals and chemical reagents, namely, cells of transgenic animals, transgenic plants and transgenic fungi, and cells of animals, plants or fungi for use in medical, pharmaceutical and veterinary laboratory research; Pharmaceutical and veterinary preparations which regulate the cellular functions of fungi, plants, bacteria and mammals and transgenic fungi, plants, bacteria and mammals; transgenic fungi and bacteria for medical and veterinary purposes; Chemicals biochemicals and reagents for veterinary and medical use, namely, chemical, biochemicals and reagents for regulating, modifying or restricting gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in regulating cellular functions, and gene expression inducers | ACTIVE | — |
| 040 | Custom manufacturing and custom synthesis of genetically engineered DNA, biological organisms, cells, viruses, pathogens and special purpose cells to the specifications of others for scientific, research, medical and laboratory use | ACTIVE | — |
| 042 | Development of new technology for others in the field of genetics, therapeutics and biotechnology; Development of products being genetic therapies and effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the fields of biotechnology and genetics, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Scientific research and product development services for others in the pharmaceutical, biotechnology, biosensors, bioelectronics, medical and agriculture fields; Gene therapy services for others for product development and scientific research purposes, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use | ACTIVE | — |
| 044 | Medical services; Medical services, namely, gene therapy services | ACTIVE | — |
| 045 | Technology transfer services, namely, licensing and transfer of intellectual property | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Intrexon Corporation
- Other trademarks owned by Intrexon Corporation
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named POWERING BETTER PRODUCTS WITH NEXT GENERATION SYNTHETIC BIOLOGY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 18, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 18, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 18, 2020 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Apr 18, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 18, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 18, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 28, 2015 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 28, 2015 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 29, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 28, 2015 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 27, 2015 | EXT5 | SOU EXTENSION 5 FILED | — |
| May 27, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 26, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 25, 2014 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 24, 2014 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 24, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 23, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 22, 2014 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 21, 2014 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 21, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 15, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 14, 2014 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 31, 2013 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 19, 2013 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 19, 2013 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 2, 2013 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 28, 2013 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 28, 2013 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 28, 2013 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 27, 2012 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 2, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 2, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 12, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 28, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 28, 2012 | ALIE | ASSIGNED TO LIE | — |
| Aug 16, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 14, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 13, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 13, 2012 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 21, 2012 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 21, 2012 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 21, 2012 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 28, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 27, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 1, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 1, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 1, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 25, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 14, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 14, 2011 | NWAP | NEW APPLICATION ENTERED | — |